rabbit a atg13 Search Results


94
Novus Biologicals ps318 atg13
(A) MEF cells expressing GFP-LC3 and mCherry-DFCP1 were pretreated for 15 min with 1 μM MRT68921 or DMSO followed by treatment with EBSS or EBSS and 1 μM MRT69821. The cells were then immediately subjected to live imaging using a Nikon Eclipse Ti wide-field microscope. (B) Representative images of cells are shown at 30 min in and asterisk marks the section highlighted in panel (B). The movies are provided as supplementary information ( and ). Scale bar, 10 μm. (A, B) Montage of the marked areas from the movies shown in (A) from minutes 22–41. Arrowheads indicate colocalisation between GFP-LC3 and mCherry-DFCP1. (B, C) Graphical representation of the maximum intensity of the mCherry-DFCP1 (red) and GFP-LC3 (green) puncta indicated with arrows in (B). (D) Quantitation of the mean time for which GFP-LC3 and mCherry-DFCP1 signals colocalised on the same punctate structure (from n = 4 events, bars represent mean with SEM). (E) Immunoblot of WT MEF cells treated with EBSS and 1 μM MRT68921 as indicated. (F) Quantitation of (E). <t>pS318-ATG13</t> levels were normalised to total ATG13 (left) and LC3-II levels were normalised to Tubulin (right). Data represent mean of n = 4 ± SEM. Statistical analysis was performed with two-way ANOVA and a Tukey’s multiple comparisons test. * = P < 0.05, ** = P < 0.01, **** = P < 0.0001 and ns, not significant. Source data are available for this figure.
Ps318 Atg13, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ps318 atg13/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
ps318 atg13 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc atg13 6940s
Crosstalk between necroptosis, autophagy, and apoptosis after mitotic catastrophe induction. ( A ) Caov4 and HCT116 cells were treated with 600 nM doxorubicin and 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 for 48 h. Immunoblot analysis using the indicated antibodies is shown. ( B ) Sub-G1 analysis of Caov4 and HCT116 cells treated with 600 nM doxorubicin and 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 for 48 h. Values are the mean (±standard deviation of the mean) of three independent experiments. ( C ) U1810 wild type and <t>ATG13-knockout</t> cells were treated with 600 nM doxorubicin and 40 μM zVAD-fmk and/or 30 μM necrostatin-1s for 24 h. Immunoblot analysis using the indicated antibodies is shown. * p < 0.05, ** p < 0.01.
Atg13 6940s, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atg13 6940s/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
atg13 6940s - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc tehnology

Tehnology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tehnology/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
tehnology - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc rabbit anti atg13

Rabbit Anti Atg13, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti atg13/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
rabbit anti atg13 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc atg13 13273

Atg13 13273, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atg13 13273/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
atg13 13273 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Addgene inc mycoplasma transfected construct h sapiens mcherry atg13

Mycoplasma Transfected Construct H Sapiens Mcherry Atg13, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mycoplasma transfected construct h sapiens mcherry atg13/product/Addgene inc
Average 93 stars, based on 1 article reviews
mycoplasma transfected construct h sapiens mcherry atg13 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Millipore rabbit anti-atg13
KEY RESOURCES TABLE
Rabbit Anti Atg13, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-atg13/product/Millipore
Average 90 stars, based on 1 article reviews
rabbit anti-atg13 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Rockland Immunochemicals anti-atg13 ps318
KEY RESOURCES TABLE
Anti Atg13 Ps318, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-atg13 ps318/product/Rockland Immunochemicals
Average 90 stars, based on 1 article reviews
anti-atg13 ps318 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arigo Biolaboratories rabbit polyclonal anti-atg13
KEY RESOURCES TABLE
Rabbit Polyclonal Anti Atg13, supplied by Arigo Biolaboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-atg13/product/Arigo Biolaboratories
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-atg13 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti phosphorylated atg13
KEY RESOURCES TABLE
Anti Phosphorylated Atg13, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti phosphorylated atg13/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
anti phosphorylated atg13 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc antibody anti-atg13

Antibody Anti Atg13, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody anti-atg13/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
antibody anti-atg13 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc p atg13
Autophagy induced by SARS-CoV-2 promotes virus replication in Vero E6 cells via the VPS34 complex. SARS-CoV-2-infected (MOI, 0.008) Vero E6 cells were harvested at different time points (0 h, 3 h, 6 h, 12 h, 24 h, 36 h, 48 h, and 72 h) after infection. (A to F) Alterations in the signaling pathway involved in the cellular autophagy machinery were analyzed by Western blotting, and this included the Akt-mTOR pathway (A), AMPK-TSC2/Raptor pathway (B), p-ULK1 (Ser 757), <t>p-Atg13</t> (Ser 355), Atg13 proteins (C), VPS34-VPS15-Beclin1 complex (D), Atg14 protein (E), and phagophore and autophagosome membrane-associated proteins (F). (G) Viral load in SARS-CoV-2-infected Vero E6 cells pretreated with SAR405 (1 μM) or 3-MA (5 mM). Cell samples were collected at 0 h, 24 h, 48 h, and 72 h after infection and analyzed by RT-qPCR. (H) Viability of Vero E6 cells treated with 3-MA after SARS-CoV-2 infection (MOI, 0.008) for 72 h. (I) Western blotting of Atg14 knockdown efficiency in Vero E6 cells. (J) Viral load in SARS-CoV-2-infected Vero E6 cells transfected with control or Atg14 siRNA. Samples were harvested at 24 hpi. (K) Western blotting of alterations in Atg5-related proteins in Atg5 −/− Vero E6 cells. (L) Viral load in SARS-CoV-2-infected Atg5 +/+ and Atg5 −/− Vero E6 cells at 24 hpi. Data were expressed as means ± SEM from three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
P Atg13, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p atg13/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
p atg13 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


(A) MEF cells expressing GFP-LC3 and mCherry-DFCP1 were pretreated for 15 min with 1 μM MRT68921 or DMSO followed by treatment with EBSS or EBSS and 1 μM MRT69821. The cells were then immediately subjected to live imaging using a Nikon Eclipse Ti wide-field microscope. (B) Representative images of cells are shown at 30 min in and asterisk marks the section highlighted in panel (B). The movies are provided as supplementary information ( and ). Scale bar, 10 μm. (A, B) Montage of the marked areas from the movies shown in (A) from minutes 22–41. Arrowheads indicate colocalisation between GFP-LC3 and mCherry-DFCP1. (B, C) Graphical representation of the maximum intensity of the mCherry-DFCP1 (red) and GFP-LC3 (green) puncta indicated with arrows in (B). (D) Quantitation of the mean time for which GFP-LC3 and mCherry-DFCP1 signals colocalised on the same punctate structure (from n = 4 events, bars represent mean with SEM). (E) Immunoblot of WT MEF cells treated with EBSS and 1 μM MRT68921 as indicated. (F) Quantitation of (E). pS318-ATG13 levels were normalised to total ATG13 (left) and LC3-II levels were normalised to Tubulin (right). Data represent mean of n = 4 ± SEM. Statistical analysis was performed with two-way ANOVA and a Tukey’s multiple comparisons test. * = P < 0.05, ** = P < 0.01, **** = P < 0.0001 and ns, not significant. Source data are available for this figure.

Journal: Life Science Alliance

Article Title: Aberrant autophagosome formation occurs upon small molecule inhibition of ULK1 kinase activity

doi: 10.26508/lsa.202000815

Figure Lengend Snippet: (A) MEF cells expressing GFP-LC3 and mCherry-DFCP1 were pretreated for 15 min with 1 μM MRT68921 or DMSO followed by treatment with EBSS or EBSS and 1 μM MRT69821. The cells were then immediately subjected to live imaging using a Nikon Eclipse Ti wide-field microscope. (B) Representative images of cells are shown at 30 min in and asterisk marks the section highlighted in panel (B). The movies are provided as supplementary information ( and ). Scale bar, 10 μm. (A, B) Montage of the marked areas from the movies shown in (A) from minutes 22–41. Arrowheads indicate colocalisation between GFP-LC3 and mCherry-DFCP1. (B, C) Graphical representation of the maximum intensity of the mCherry-DFCP1 (red) and GFP-LC3 (green) puncta indicated with arrows in (B). (D) Quantitation of the mean time for which GFP-LC3 and mCherry-DFCP1 signals colocalised on the same punctate structure (from n = 4 events, bars represent mean with SEM). (E) Immunoblot of WT MEF cells treated with EBSS and 1 μM MRT68921 as indicated. (F) Quantitation of (E). pS318-ATG13 levels were normalised to total ATG13 (left) and LC3-II levels were normalised to Tubulin (right). Data represent mean of n = 4 ± SEM. Statistical analysis was performed with two-way ANOVA and a Tukey’s multiple comparisons test. * = P < 0.05, ** = P < 0.01, **** = P < 0.0001 and ns, not significant. Source data are available for this figure.

Article Snippet: The following antibodies were purchased from CST: ULK1 (8054S), pS757 ULK1 (6888T), pS555 ULK1 (5869S) and LC3 A/B (4108S—used for Western blot). pS318-ATG13 (NBP2-19127) was from Novus Biologicals.

Techniques: Expressing, Imaging, Microscopy, Quantitation Assay, Western Blot

(A) Immunoblot of lysates from MEF cells treated with EBSS, 50 nM BafA1, 1 μM MRT68921, 10 μM SBI0206965, and 1 μM ULK-101 for 1 h as indicated. (B) Quantitation of pS318-ATG13 levels normalised to total ATG13 (top) and LC3-II levels normalised to α-Tubulin (bottom). Data represent mean of n = 4 ± SEM. Statistical analysis was performed with two-way ANOVA and a Tukey’s multiple comparisons test. * = P < 0.05, ** = P < 0.01, *** = P < 0.001, **** = P < 0.0001 and ns, nonsignificant (unless indicated comparisons of each treatment are with the relevant DMSO control). (C) Representative flow cytometry assay of MEF cells expressing mCherry-GFP-LC3 treated with either DMSO or 50 nM BafA1, or 4 μM MRT68921, or 20 μM SBI0206965, or 2 μM ULK-101 in EBSS for 4 h as indicated, where a decrease/increase in GFP and mCherry expression can be observed and quantified to measure the percent of cells undergoing autophagy. The number in each panel indicates % of cells undergoing autophagy. Quantitation of the flow data is shown on the right and represents mean of n = 3 ± SEM. Statistical analysis was performed with one-way ANOVA and a Tukey’s multiple comparisons test. **** = P < 0.0001. Source data are available for this figure.

Journal: Life Science Alliance

Article Title: Aberrant autophagosome formation occurs upon small molecule inhibition of ULK1 kinase activity

doi: 10.26508/lsa.202000815

Figure Lengend Snippet: (A) Immunoblot of lysates from MEF cells treated with EBSS, 50 nM BafA1, 1 μM MRT68921, 10 μM SBI0206965, and 1 μM ULK-101 for 1 h as indicated. (B) Quantitation of pS318-ATG13 levels normalised to total ATG13 (top) and LC3-II levels normalised to α-Tubulin (bottom). Data represent mean of n = 4 ± SEM. Statistical analysis was performed with two-way ANOVA and a Tukey’s multiple comparisons test. * = P < 0.05, ** = P < 0.01, *** = P < 0.001, **** = P < 0.0001 and ns, nonsignificant (unless indicated comparisons of each treatment are with the relevant DMSO control). (C) Representative flow cytometry assay of MEF cells expressing mCherry-GFP-LC3 treated with either DMSO or 50 nM BafA1, or 4 μM MRT68921, or 20 μM SBI0206965, or 2 μM ULK-101 in EBSS for 4 h as indicated, where a decrease/increase in GFP and mCherry expression can be observed and quantified to measure the percent of cells undergoing autophagy. The number in each panel indicates % of cells undergoing autophagy. Quantitation of the flow data is shown on the right and represents mean of n = 3 ± SEM. Statistical analysis was performed with one-way ANOVA and a Tukey’s multiple comparisons test. **** = P < 0.0001. Source data are available for this figure.

Article Snippet: The following antibodies were purchased from CST: ULK1 (8054S), pS757 ULK1 (6888T), pS555 ULK1 (5869S) and LC3 A/B (4108S—used for Western blot). pS318-ATG13 (NBP2-19127) was from Novus Biologicals.

Techniques: Western Blot, Quantitation Assay, Control, Flow Cytometry, Expressing

(A, B) Quantification of pS757 ULK1 levels (A) and pS555 ULK1 levels (B) normalised to total ULK1. Bars represent mean of n = 4 ± SEM. Statistical analysis was performed with a two-way ANOVA and a Tukey’s multiple comparisons test. The presence of the inhibitors resulted in no significant changes among the different conditions. This figure is complementary to . (C) Co-immunoprecipitation of ULK1 with FIP200 and ATG13 from cells growing in Fed or EBSS conditions treated with 2 μM MRT68921, or 1 μM ULK-101, or 5 μM SBI0206965 or DMSO for 1 h, as indicated. Source data are available for this figure.

Journal: Life Science Alliance

Article Title: Aberrant autophagosome formation occurs upon small molecule inhibition of ULK1 kinase activity

doi: 10.26508/lsa.202000815

Figure Lengend Snippet: (A, B) Quantification of pS757 ULK1 levels (A) and pS555 ULK1 levels (B) normalised to total ULK1. Bars represent mean of n = 4 ± SEM. Statistical analysis was performed with a two-way ANOVA and a Tukey’s multiple comparisons test. The presence of the inhibitors resulted in no significant changes among the different conditions. This figure is complementary to . (C) Co-immunoprecipitation of ULK1 with FIP200 and ATG13 from cells growing in Fed or EBSS conditions treated with 2 μM MRT68921, or 1 μM ULK-101, or 5 μM SBI0206965 or DMSO for 1 h, as indicated. Source data are available for this figure.

Article Snippet: The following antibodies were purchased from CST: ULK1 (8054S), pS757 ULK1 (6888T), pS555 ULK1 (5869S) and LC3 A/B (4108S—used for Western blot). pS318-ATG13 (NBP2-19127) was from Novus Biologicals.

Techniques: Immunoprecipitation

Crosstalk between necroptosis, autophagy, and apoptosis after mitotic catastrophe induction. ( A ) Caov4 and HCT116 cells were treated with 600 nM doxorubicin and 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 for 48 h. Immunoblot analysis using the indicated antibodies is shown. ( B ) Sub-G1 analysis of Caov4 and HCT116 cells treated with 600 nM doxorubicin and 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 for 48 h. Values are the mean (±standard deviation of the mean) of three independent experiments. ( C ) U1810 wild type and ATG13-knockout cells were treated with 600 nM doxorubicin and 40 μM zVAD-fmk and/or 30 μM necrostatin-1s for 24 h. Immunoblot analysis using the indicated antibodies is shown. * p < 0.05, ** p < 0.01.

Journal: International Journal of Molecular Sciences

Article Title: Necroptosis as a Novel Facet of Mitotic Catastrophe

doi: 10.3390/ijms23073733

Figure Lengend Snippet: Crosstalk between necroptosis, autophagy, and apoptosis after mitotic catastrophe induction. ( A ) Caov4 and HCT116 cells were treated with 600 nM doxorubicin and 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 for 48 h. Immunoblot analysis using the indicated antibodies is shown. ( B ) Sub-G1 analysis of Caov4 and HCT116 cells treated with 600 nM doxorubicin and 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 for 48 h. Values are the mean (±standard deviation of the mean) of three independent experiments. ( C ) U1810 wild type and ATG13-knockout cells were treated with 600 nM doxorubicin and 40 μM zVAD-fmk and/or 30 μM necrostatin-1s for 24 h. Immunoblot analysis using the indicated antibodies is shown. * p < 0.05, ** p < 0.01.

Article Snippet: The membranes were incubated with primary antibodies against cleaved PARP-1 (Asp214) (9541S), RIP1 (4926S), phospho-RIP (Ser166) (65746S), caspase-3 (9662S), cleaved caspase-3 (9664S), and ATG13 (6940S) (all from Cell Signaling Technology, Danvers, MA, USA), PARP-1 (ab137653), p62/SQSTM1 (ab56416), LC3B (ab51520), and vinculin (ab129002) (all from Abcam, Eugene, OR, USA), and FADD (gift from Prof. Inna Lavrik, Otto von Guericke University Magdeburg, Magdeburg, Germany) overnight at 4 °C.

Techniques: Western Blot, Standard Deviation, Knock-Out

Caspase inhibition increases the population of cells with mitotic catastrophe morphology. ( A ) Quantification of mitotic catastrophe after 48 h treatment with 600 nM doxorubicin in combination with 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 in Caov4 and HCT116 cells. ( B ) Quantification of mitotic catastrophe after 24 h of treatment with 600 nM doxorubicin in combination with 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s in wild type and ATG13-knockout U1810 cells. The number of mitotic catastrophe cells examined in each cell line are shown in the bars. Values are the mean (±standard deviation of the mean) of three independent experiments. * p < 0.05, ** p < 0.01, ns—not significant.

Journal: International Journal of Molecular Sciences

Article Title: Necroptosis as a Novel Facet of Mitotic Catastrophe

doi: 10.3390/ijms23073733

Figure Lengend Snippet: Caspase inhibition increases the population of cells with mitotic catastrophe morphology. ( A ) Quantification of mitotic catastrophe after 48 h treatment with 600 nM doxorubicin in combination with 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s, and/or 25 nM bafilomycin A1 in Caov4 and HCT116 cells. ( B ) Quantification of mitotic catastrophe after 24 h of treatment with 600 nM doxorubicin in combination with 40 μM zVAD-fmk, and/or 30 μM necrostatin-1s in wild type and ATG13-knockout U1810 cells. The number of mitotic catastrophe cells examined in each cell line are shown in the bars. Values are the mean (±standard deviation of the mean) of three independent experiments. * p < 0.05, ** p < 0.01, ns—not significant.

Article Snippet: The membranes were incubated with primary antibodies against cleaved PARP-1 (Asp214) (9541S), RIP1 (4926S), phospho-RIP (Ser166) (65746S), caspase-3 (9662S), cleaved caspase-3 (9664S), and ATG13 (6940S) (all from Cell Signaling Technology, Danvers, MA, USA), PARP-1 (ab137653), p62/SQSTM1 (ab56416), LC3B (ab51520), and vinculin (ab129002) (all from Abcam, Eugene, OR, USA), and FADD (gift from Prof. Inna Lavrik, Otto von Guericke University Magdeburg, Magdeburg, Germany) overnight at 4 °C.

Techniques: Inhibition, Knock-Out, Standard Deviation

Journal: Molecular Cell

Article Title: The Cargo Receptor NDP52 Initiates Selective Autophagy by Recruiting the ULK Complex to Cytosol-Invading Bacteria

doi: 10.1016/j.molcel.2019.01.041

Figure Lengend Snippet:

Article Snippet: Rabbit monoclonal anti-ATG13 (E1Y9V) , Cell Signaling Tehnology , Cat# 13468.

Techniques: Luciferase, Transduction, Recombinant, Plasmid Preparation, Protease Inhibitor, Negative Control, Software, Chromatography, Molecular Weight

KEY RESOURCES TABLE

Journal: Molecular cell

Article Title: ULK1/2 Regulates Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97

doi: 10.1016/j.molcel.2019.03.027

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Rabbit anti-ATG13 , Sigma-Aldrich , Cat# SAB4200100; RRID:AB_10602787.

Techniques: Recombinant, Western Blot, Software

Journal: eLife

Article Title: Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer

doi: 10.7554/eLife.96992

Figure Lengend Snippet:

Article Snippet: Antibody , Anti-ATG13 (rabbit monoclonal) , Cell Signaling Technology , Cat# 13272 , ELISA (1:500).

Techniques: Plasmid Preparation, Enzyme-linked Immunosorbent Assay, Recombinant

Autophagy induced by SARS-CoV-2 promotes virus replication in Vero E6 cells via the VPS34 complex. SARS-CoV-2-infected (MOI, 0.008) Vero E6 cells were harvested at different time points (0 h, 3 h, 6 h, 12 h, 24 h, 36 h, 48 h, and 72 h) after infection. (A to F) Alterations in the signaling pathway involved in the cellular autophagy machinery were analyzed by Western blotting, and this included the Akt-mTOR pathway (A), AMPK-TSC2/Raptor pathway (B), p-ULK1 (Ser 757), p-Atg13 (Ser 355), Atg13 proteins (C), VPS34-VPS15-Beclin1 complex (D), Atg14 protein (E), and phagophore and autophagosome membrane-associated proteins (F). (G) Viral load in SARS-CoV-2-infected Vero E6 cells pretreated with SAR405 (1 μM) or 3-MA (5 mM). Cell samples were collected at 0 h, 24 h, 48 h, and 72 h after infection and analyzed by RT-qPCR. (H) Viability of Vero E6 cells treated with 3-MA after SARS-CoV-2 infection (MOI, 0.008) for 72 h. (I) Western blotting of Atg14 knockdown efficiency in Vero E6 cells. (J) Viral load in SARS-CoV-2-infected Vero E6 cells transfected with control or Atg14 siRNA. Samples were harvested at 24 hpi. (K) Western blotting of alterations in Atg5-related proteins in Atg5 −/− Vero E6 cells. (L) Viral load in SARS-CoV-2-infected Atg5 +/+ and Atg5 −/− Vero E6 cells at 24 hpi. Data were expressed as means ± SEM from three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Journal: Journal of Virology

Article Title: Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues

doi: 10.1128/JVI.01537-21

Figure Lengend Snippet: Autophagy induced by SARS-CoV-2 promotes virus replication in Vero E6 cells via the VPS34 complex. SARS-CoV-2-infected (MOI, 0.008) Vero E6 cells were harvested at different time points (0 h, 3 h, 6 h, 12 h, 24 h, 36 h, 48 h, and 72 h) after infection. (A to F) Alterations in the signaling pathway involved in the cellular autophagy machinery were analyzed by Western blotting, and this included the Akt-mTOR pathway (A), AMPK-TSC2/Raptor pathway (B), p-ULK1 (Ser 757), p-Atg13 (Ser 355), Atg13 proteins (C), VPS34-VPS15-Beclin1 complex (D), Atg14 protein (E), and phagophore and autophagosome membrane-associated proteins (F). (G) Viral load in SARS-CoV-2-infected Vero E6 cells pretreated with SAR405 (1 μM) or 3-MA (5 mM). Cell samples were collected at 0 h, 24 h, 48 h, and 72 h after infection and analyzed by RT-qPCR. (H) Viability of Vero E6 cells treated with 3-MA after SARS-CoV-2 infection (MOI, 0.008) for 72 h. (I) Western blotting of Atg14 knockdown efficiency in Vero E6 cells. (J) Viral load in SARS-CoV-2-infected Vero E6 cells transfected with control or Atg14 siRNA. Samples were harvested at 24 hpi. (K) Western blotting of alterations in Atg5-related proteins in Atg5 −/− Vero E6 cells. (L) Viral load in SARS-CoV-2-infected Atg5 +/+ and Atg5 −/− Vero E6 cells at 24 hpi. Data were expressed as means ± SEM from three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Article Snippet: Antibodies against Atg5 (2630), p-AKT (4060), AKT (4685), p-mTOR (5536), mTOR (2983), p-S6 (4858), S6 (2317), p-4E-BP1 (2855), 4E-BP1 (9644), p-AMPK (2535), AMPK (5831), p-TSC-2 (3614), TSC-2 (4308), p-Raptor (2083), Raptor (2280), p-Atg13 (26839), Atg13 (13273), ULK1 (8054), p-ULK1 (Ser757) (14202), p-ULK1 (Ser555) (5869), VPS15 (14580), VPS34 (4263), Beclin1 (3495), p-Beclin1 (84966), Atg14 (96752), Atg16L1 (8089), p62 (16177), and GAPDH (5174) were obtained from Cell Signaling Technology (Danvers, MA).

Techniques: Virus, Infection, Western Blot, Membrane, Quantitative RT-PCR, Knockdown, Transfection, Control